First Look Analyst Calls Briefing for Friday, November 4, 2022 

Photo of Paul Ausick
By Paul Ausick Published
First Look Analyst Calls Briefing for Friday, November 4, 2022 

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today.

Upgrades:

> Advanced Energy (AEIS) upgraded to Buy from Neutral at Citigroup; tgt lowered to $95

> Coherent (COHR) upgraded to Buy from Neutral at Citigroup; tgt lowered to $52

> Cohu (COHU) upgraded to Buy from Neutral at Citigroup; tgt raised to $45

> Karyopharm Therapeutics (KPTI) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $10

> Penumbra (PEN) upgraded to Buy from Neutral at Citigroup; tgt lowered to $212

Downgrades:

> ACADIA Pharmaceuticals (ACAD) downgraded to Sell from Neutral at Goldman; tgt lowered to $12

> Arconic (ARNC) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $22

> Aurinia Pharma (AUPH) downgraded to Perform from Outperform at Oppenheimer

> BigCommerce (BIGC) downgraded to Hold from Buy at Truist; tgt $13

> C4 Therapeutics (CCCC) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $15

> EchoStar (SATS) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $27

> Fidelity Nat’l Info (FIS) downgraded to Perform from Outperform at Oppenheimer

> Frontdoor (FTDR) downgraded to Mkt Perform from Outperform at Raymond James

> Funko (FNKO) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $16

> GoPro (GPRO) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $6

> HireRight Holdings (HRT) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $12

> MKS Instruments (MKSI) downgraded to Hold from Buy at The Benchmark Company

> Prothena (PRTA) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt raised to $55

> Spirit Aerosystems (SPR) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $29

Others:

> Allscripts Healthcare (MDRX) assumed with an Overweight at Piper Sandler; tgt $17

Contact [email protected] for any questions or corrections.

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

ABNB Vol: 15,913,532
MCHP Vol: 19,139,274
PLTR Vol: 77,244,625
MRNA Vol: 6,820,582
AXON Vol: 1,591,869

Top Losing Stocks

TTD Vol: 133,458,224
CTRA Vol: 73,319,495
AKAM Vol: 8,143,961
ZTS Vol: 12,784,553
RMD Vol: 3,810,438